You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CRM

Showing 1 - 25 of 596
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiac Rhythm Disorder, Heart Failure, Sudden Cardiac Death Trial (Implantation of a CIED)

Not yet recruiting
  • Cardiac Rhythm Disorder
  • +2 more
  • Implantation of a CIED
  • (no location specified)
Jan 20, 2023

Malaria,Falciparum Trial in Bamako (MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine)

Not yet recruiting
  • Malaria,Falciparum
  • MSP3-CRM-Vac4All/ Alhydrogel®
  • Anti-Rabies Vaccine
  • Bamako, Mali
    Malaria Research and Training Center (MRTC), University of Scien
Mar 7, 2023

Epidemic Meningitis Trial (MCV4)

Not yet recruiting
  • Epidemic Meningitis
  • MCV4
  • (no location specified)
Jul 5, 2023

Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of

Not yet recruiting
  • Meningococcal Meningitis
  • batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
  • +3 more
  • Surabaya, Indonesia
    Husada Utama Hospital
Nov 13, 2023

Epidemic Meningitis Trial (MCV4, MSPV4)

Not yet recruiting
  • Epidemic Meningitis
  • MCV4
  • MSPV4
  • (no location specified)
Aug 21, 2023

Mood Disorders, Bipolar I Disorder, Bipolar II Disorder Trial in Seoul (Circadian Rhythms for Mood (CRM) application - Active,

Recruiting
  • Major Depressive Disorder
  • +2 more
  • Circadian Rhythms for Mood (CRM) application - Active
  • Circadian Rhythms for Mood (CRM) application - Sham
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Dec 20, 2022

Malaria,Falciparum Trial in Bamako (MSP3-CRM-Vac4All/ Alhydrogel®)

Recruiting
  • Malaria,Falciparum
  • MSP3-CRM-Vac4All/ Alhydrogel®
  • Bamako, Mali
    Malaria Research and Training Center (MRTC), University of Scien
Jan 5, 2022

Pneumococcal Infections, Streptococcal Infections, Bacterial Infections Trial in Anyang (13-Valent Pneumococcal Polysaccharide

Active, not recruiting
  • Pneumococcal Infections
  • +2 more
  • 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine（CRM197,TT）
  • 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
  • Anyang, Henan, China
    Neihuang Center for Disease Control and Prevention
Oct 28, 2022

Metastatic Gastric Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer Trial in New Taipei City, Taipei

Completed
Has Results
  • Metastatic Gastric Cancer
  • +3 more
  • New Taipei City, Taiwan
  • +3 more
Sep 21, 2022

Healthy Trial in Germany (TK-254RX)

Not yet recruiting
  • Healthy
  • Brühl, Germany
  • +3 more
Sep 14, 2023

Primary Percutaneous Coronary Intervention Guidance Using

Active, not recruiting
  • ST Elevation Myocardial Infarction
  • +5 more
    • Rotterdam, Netherlands
      Erasmus University Medical Center
    Jan 16, 2023

    Healthy Volunteers (Meningococcal Infection) Trial in Buenos Aires (MenACYW conjugate vaccine)

    Not yet recruiting
    • Healthy Volunteers (Meningococcal Infection)
    • MenACYW conjugate vaccine
    • Buenos Aires, Ciudad De Buenos Aires, Argentina
      Investigational Site Number :0320002
    Jul 7, 2023

    Healthy Trial in London (3SM2-G-CRM197 with squalene adjuvant)

    Completed
    • Healthy
    • 3SM2-G-CRM197 with squalene adjuvant
    • London, Please Select..., United Kingdom
      NIHR Imperial Clinical Research Facility
    Jul 25, 2022

    PCOS, Polycystic Ovary Syndrome Trial in Charlottesville (Micronized progesterone, Placebo, Flutamide)

    Recruiting
    • PCOS
    • Polycystic Ovary Syndrome
    • Micronized progesterone
    • +3 more
    • Charlottesville, Virginia
      University of Virginia
    May 16, 2022

    Ageing and Acute Care Physicians' Performance

    Active, not recruiting
    • Ageing
    • CRM Simulation
    • Ottawa, Ontario, Canada
    • +1 more
    Feb 8, 2022

    Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)

    Active, not recruiting
    • Recurrent Melanoma
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Sep 5, 2022

    Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

    Recruiting
    • Recurrent Histiocytic and Dendritic Cell Neoplasm
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 5, 2022

    Pneumonia, Aging Trial in Farmington (Pneumococcal 13valent Conj Vaccine Diphtheria CRM197 Protein, Pneumococcal Vaccine

    Completed
    Has Results
    • Pneumonia
    • Aging
    • Pneumococcal 13valent Conj Vaccine Diphtheria CRM197 Protein
    • Pneumococcal Vaccine Polyvalent
    • Farmington, Connecticut
      UConn Center On Aging
    Nov 8, 2021

    STEMI Trial in Sheffield (Cardiovascular Magnetic Resonance Scan)

    Withdrawn
    • STEMI
    • Cardiovascular Magnetic Resonance Scan
    • Sheffield, England, United Kingdom
      Sheffield Teaching Hospitals NHS FT
    May 13, 2022

    Colorectal Tumor, Effects of Radiation Therapy, Effects of Chemo Trial in China (procedure, radiation, drug)

    Suspended
    • Colorectal Neoplasm
    • +3 more
    • Rectectomy
    • +3 more
    • Fuzhou, Fujian, China
    • +6 more
    May 5, 2022

    Pneumococcal Infections, Streptococcal Infections, Bacterial Infections Trial in Anyang (13-Valent Pneumococcal Polysaccharide

    Active, not recruiting
    • Pneumococcal Infections
    • +2 more
    • 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine（CRM197,TT）
    • 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
    • Anyang, Henan, China
      Neihuang Center for Disease Control and Prevention
    Aug 2, 2021

    B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial (Decreasing starting times for beginning

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia
    • Acute Lymphoblastic Leukemia, in Relapse
    • Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) )
    • Nivolumab starting at day -1
    • (no location specified)
    Apr 4, 2022

    Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

    Recruiting
    • Advanced Urothelial Carcinoma
    • +3 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jun 28, 2022

    MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

    Not yet recruiting
    • MGMT-Methylated Glioblastoma
    • Recurrent Glioblastoma, IDH-Wildtype
    • (no location specified)
    Jun 28, 2022

    Meningococcal Disease, Invasive Trial in Calgary, Vancouver, Halifax (MenACWY-CRM, MenACWY-DT, MenACWY-TT)

    Completed
    • Meningococcal Disease, Invasive
    • MenACWY-CRM
    • +2 more
    • Calgary, Alberta, Canada
    • +2 more
    Mar 10, 2022